Our Trials

Currently recruiting:

Overactive Bladder

Canterbury Urology Research Trust are currently recruiting subjects for a new device for Overactive Bladder(OAB)

The Principal Investigator for this study is Dr Sharon English

This study looks at the use of the Valencia Technologies eCoin system to stimulate the tibial nerve. The device is approximately the size of a New Zealand 50 cent coin. It is implanted under the skin just above the ankle bone. This will give small electrical impulses into the nerve in an attempt to improve or restore normal control of your bladder.

Inclusion Criteria includes:

  • Women and Men 18 years or older
  • Overactive bladder with urgency and incontinence for at least 6 months
  • Is currently on or has tried medication for OAB
Contact us for more information

 

Prostate Cancer (metastatic)

The objective of this phase III study is to determine the benefit of Enzalutamide plus hormone deprivation therapy compared to placebo plus hormone deprivation.

The Principal Investigator for this study is Dr Nicholas Buchan

Eligibility criteria includes:

  • Diagnosis of metastatic prostate cancer
Contact us for more information

Past trials

If you would like more information about any of our trials, please feel free to contact us.

 

Click on the name of the trial for more information (please note currently only some trials have more information).

Subject Status Actual Quota Start Date
Overactive Bladder Completed 2 2 August 2014
Prostate Cancer with metastases Completed 4 4 May 2014
Overactive Bladder with Incontinence Recruiting completed 8 10 May 2017
Hormone Resistant Prostate Cancer – with metastases Recruiting 5 September 2016
Benign Prostatic Hyperplasia Completed competetive October 2016
Overactive Bladder – for patients with MS or spinal cord injury Recruiting closed early 4 27 May 2016
Benign Prostatic Hyperplasia Completed 5 5 April 2014
Overactive Bladder Completed 4 - difficult inclusion/exclusion criteria to recruit for 10 March 2014
Prostate Cancer – Observational Study Completed 2 5 March 2014
Prostate Cancer; hormone resistant, no metastases Recruiting completed 3 5 March 2014
Prostate Cancer; newly diagnosed, metastatic Completed 3 5 June 2013
Bladder cancer; monitoring Completed 107 80 January 2012
Bladder cancer; evaluation Completed 91 80 January 2012
Prostate Cancer; Hormone resistant Completed 5 5 April 2011
Overactive bladder Completed 6 12 March 2011
Peyronies Completed 10 Open December 2010
Prostate Cancer; Stable Completed 5 Open July 2010
Prostate Cancer; Hormone resistant Completed 4 20 June 2010
Soft Tissue Injury Completed 7 10 May 2009
DVT Prevention Completed 10 8 October 2008
Diverticulitis Completed 2 8 June 2008
Haematuria Completed 187 Open May 2008
Prostate Cancer; hormone resistant Completed 3 5 December 2007
Prostate Cancer; hormone resistant Completed 16 5 December 2007
Overactive Bladder (adult) Completed 8 8 October 2006
Prostate Cancer; stable Completed 31 15 September 2005
Overactive Bladder; M/S and Spinal Completed 8 10 September 2006
Overactive Bladder (adult) Completed 7 7 September 2006
Prostate Cancer; hormone resistant Recruiting completed 16 5 July 2006
Overactive Bladder (adult); medical treatment Completed 2 10 July 2006
Prostate Cancer; Hormone resistant Completed 11 8 June 2006
Overactive Bladder (adult); medical treatment Recruiting closed early 5 8 April 2006
Diabetes Completed 2 7 April 2006
Testicular Cancer Recruiting completed 120 Open March 2006
Dyslipidaemia; high blood cholesterol Completed 5 7 March 2006
Overactive Bladder (adult) Completed 17 15 February 2006
Atrial Fibrillation Completed 1 10 February 2006
Japanese Encephalitis Recruiting closed early 28 75 October 2005
Osteoarthritis of the knee Recruiting closed early 4 10 July 2005
Rheumatoid Arthritis; General Completed 3 10 April 2005
Prostate Cancer; Hormone resistant Completed 7 4 March 2005
Crohns extension; medical treatment Completed 1 1 November 2004
Asthma; Moderate to severe Recruiting closed early 6 10 October 2004
Rhinitis Completed 11 10 September 2004
Overactive Bladder (adult); open label extension Completed 11 12 July 2004
Crohns; medical treatment Recruiting closed early 2 5 July 2004
Overactive Bladder (adult) Completed 17 10 February 2004
Prostate Cancer; Prevention Completed 31 30 June 2003
Irritable Bowel Syndrome; constipated predominant Completed 11 10 May 2003
Male Erectile Dysfunction; Completed 22 10 April 2003
Benign Prostatic Hyperplasia; Non pharmaceutical Completed 26 27 April 2003
Male Erectile Dysfunction Recruiting closed early 6 8 December 2002
Post operative analgesia Recruiting closed early 6 10 November 2002
Benign Prostatic Hyperplasia; medical treatment Completed 22 12 November 2002
Prostate Cancer; Hormone resistant Completed 13 8 October 2002
Overactive Bladder (paediatric) extension medical treatment Completed 5 5 September 2002
Asthma; Mild Completed 6 7 June 2002
Overactive Bladder (paediatric); medical treatment Completed 5 6 May 2002
Irritable Bowel Syndrome; diarrhoea predominant Completed 8 7 March 2002
A Kidney Stone Study; community study on the burden of stone disease; non pharmaceutical Completed 282 Open November 2001
Overactive Bladder (adult); medical treatment Completed 31 36 September 2001
Overactive Bladder (adult); medical treatment Completed 32 30 March 2001
Male Erectile Dysfunction; medical treatment Completed 10 10 December 2000
Influenza; prevention Completed 3 30 March 2000
Prostate Cancer; Hormone resistant Completed 14 8 November 1999
Female Stress Incontinence; urethral device Completed 14 10 November 1999
Benign Prostatic Hyperplasia; medical treatment Completed 17 17 November 1999
Benign Prostatic Hyperplasia; genotyping Completed 20 20 November 1999
Female Stress Incontinence; urethral device Completed 12 12 July 1999
Benign Prostatic Hyperplasia; medical treatment Completed 22 24 July 1999
Prostate Cancer; Hormone resistant Recruiting closed early 3 8 November 1998
Benign Prostatic Hyperplasia; medical treatment Completed 32 24 November 1997